Precigen

About Precigen

Precigen Inc is a discovery and clinical-stage biopharmaceutical company specializing in the development of gene and cell therapies using precision technology. The company targets diseases in immuno-oncology, autoimmune disorders, and infectious diseases through innovative therapeutic platforms such as UltraCAR-T, AdenoVerse immunotherapy, and ActoBiotics. Precigen advances a pipeline of therapies designed to address urgent and intractable diseases, leveraging proprietary technologies to deliver next-generation biotherapeutics. The company also provides devices and research models for healthcare research applications. Formerly known as Intrexon Corporation, Precigen is headquartered in Germantown, Maryland, and serves customers worldwide.